Rosuvastatin for Tocilizumab, an Interleukin-6 Receptor Antibody-Induced Dyslipidemia in a Diabetic Patient Complicated With Rheumatoid Arthritis

Journal of Endocrinology and Metabolism - Canada
doi 10.4021/jem51w
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elmer Press, Inc.

Related search

Tocilizumab, a Humanized Anti-Interleukin-6 Receptor Antibody, for Treatment of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2011English

Exacerbation of Chronic Active Epstein-Barr Virus Infection in a Patient With Rheumatoid Arthritis Receiving Humanised Anti-Interleukin-6 Receptor Monoclonal Antibody

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2006English

Dramatic Radiographic Repair by Tocilizumab in a Very Elderly Patient With Rheumatoid Arthritis

Modern Rheumatology
MedicineRheumatology
2013English

Acute Anterior Uveitis After Discontinuation of Tocilizumab in a Patient With Rheumatoid Arthritis

Clinical Ophthalmology
Ophthalmology
2014English

Immunotherapy of Tocilizumab for Rheumatoid Arthritis

Journal of Clinical & Cellular Immunology
2013English

Atorvastatin Versus Rosuvastatin in Non-Diabetic Patients With Dyslipidemia: A Comparative Study

International Journal of Basic and Clinical Pharmacology
2016English

B-Lymphocyte Subpopulations in Patients With Rheumatoid Arthritis and the Effect of an Interleukin-6 Receptor Inhibitor on Them.

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2019English

Interleukin-6 Inhibition and Cardiovascular Disease in Patients With Rheumatoid Arthritis

Terapevticheskii Arkhiv
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Minimal Physiologically-Based Pharmacokinetic (mPBPK) Model for a Monoclonal Antibody Against Interleukin-6 in Mice With Collagen-Induced Arthritis

Journal of Pharmacokinetics and Pharmacodynamics
Pharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy